ABSTRACT. To determine the usefulness of MspI/int22h-1 (intron 22 homologous region-1) polymorphism of the factor VIII gene for molecular genetic diagnosis of hemophilia A in the Korean population, MspI/intron 22 and XbaI/intron 22 polymorphisms were analyzed in 101 unrelated Korean families with severe hemophilia A. The expected heterozygosity rates of MspI/int22h-1 and XbaI/ int22h-1 polymorphisms were 49.5 and 43.6%, respectively; these polymorphisms were not in complete linkage disequilibrium. Combined analysis using both polymorphisms provided an informative rate of 66.3%. These results suggest that PCR analysis of the MspI/ int22h-1 polymorphism of the factor VIII gene would be useful for 
INTRODUCTION
Hemophilia A is one of the most common bleeding disorders in humans, affecting 1 in 5,000-10,000 males. The disorder is caused by mutations in the factor VIII gene (Gitschier et al., 1984; Bowen, 2002) . The factor VIII gene is located toward the end of the long arm of the X-chromosome (Xq28) and, at 180 kb and containing 26 exons, is an extremely large gene (Gitschier et al., 1984) . More than 900 different kinds of mutations are known to cause hemophilia A (Tuddenham et al., 1994) , but except for one case of inversion, no specific mutational hot spot has been reported. The inversion involves intron 22 of the factor VIII gene and is found in 40-50% of patients with severe hemophilia A (Lakich et al., 1993; Naylor et al., 1993) . The inversion can be identified by a direct analysis of the mutation using a long PCR assay method (Liu et al., 1998) . However, except for this inversion, it is very difficult to identify specific gene mutations in patients in order to detect carriers and perform prenatal diagnoses. Thus, in cases lacking the inversion, gene polymorphisms have been commonly used for mutational linkage analysis to diagnose the disease.
To perform molecular genetic diagnoses of hemophilia A, gene polymorphisms are most commonly analyzed with extragenic markers such as St14 VNTR (variable number of tandem repeats) (Richards et al., 1991) , intragenic markers such as the BclI/intron 18 polymorphism (Gitschier et al., 1985) , hypervariable dinucleotide repeats of intron 13 (Lalloz et al., 1991) and intron 22 (Lalloz et al., 1992 (Lalloz et al., , 1994 , and the XbaI/intron 22 polymorphism (Wion et al., 1986) . The intragenic intron 22 (int22h-1; intron 22 homologous region-1) of the factor VIII gene has a similar gene sequence at two locations (int22h-2, int22h-3) of the extragenic Xq telomere, where gene polymorphisms also exist (Levinson et al., 1990 (Levinson et al., , 1992 Naylor et al., 1995) . Therefore, specific information about int22h-1 gene polymorphisms would be important for accurate diagnosis. The XbaI and MspI polymorphisms are located within a 9.5-kb stretch of the int22h-1 sequence. The extragenic homologous sequences, int22h2-2 and int22h-3, also have polymorphic sites for XbaI and MspI (Chan et al., 1989; Naylor et al., 1995; Bowen et al., 2000) . Thus, detection of XbaI/int22h-1 and MspI/int22h-1 polymorphisms at the three polymorphic sites of int22h would require efficient amplification of those specific sequences (De Brasi et al., 1999; El-Maarri et al., 1999) .
The MspI polymorphism is located 737 bases downstream from the XbaI polymorphism (Bowen et al., 2000) . Despite their close proximity to each other, these polymorphisms are known to not be in complete linkage disequilibrium. Bowen et al. (2000) reported that when 85 male residents of South Wales were studied, the informative rate increased to 60% through the combined use of MspI and XbaI polymorphisms of int22h-1. This finding, however, has not been shown to be applicable to people of other regions, especially Asian countries. With this thought in mind, we investigated the degree of linkage disequilibrium of both XbaI and MspI polymorphisms in a Korean population, which could be used for carrier detection and prenatal diagnosis of hemophilia A.
MATERIAL AND METHODS

Subjects
We recruited 101 unrelated Korean families with hemophilia A during the period 1992 to 2004, who visited Korea Hemophilia Foundation for the purpose of carrier detection and prenatal diagnosis of hemophilia A. The review board for human research of Seoul National University Hospital approved this project.
Genomic DNA extraction
Genomic DNA was extracted from peripheral blood with a Wizard genomic DNA purification kit (Promega, Madison, WI, USA). The concentration of extracted DNA was measured with a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). Each DNA sample was analyzed after normalizing the concentration to 50 ng/μL.
Analysis of XbaI/int22h-1 polymorphism
PCR was performed in a 25-μL total reaction volume containing 200 ng genomic DNA, Takara LA Taq buffer (Takara Bio Inc., Kyoto, Japan), 7.5% DMSO (dimethyl sulfoxide), 250 μM each of dGTP and 7-deaza-dGTP (Boehringer Mannheim, Mannheim, Germany), 500 μM of the other dNTPs (Boehringer Mannheim), 1 U LA Taq DNA polymerase (Takara Bio Inc.), 0.2 μM each of the forward and reverse primers. The forward primer was 5'-GCCCTGCCTGTCCATTACACTGATGACATTATGCTGAC-3' and the reverse primer was 5'-TTCAACACGACCACCATCTCTCAAGTGGCC-3'. PCR cycling was performed in an MJR PTC200 thermocycler (MJ Research, Waltham, MA, USA) as follows: 94°C for 2 min, followed by 30 cycles at 94°C for 12 s, 65°C for 30 s, 60°C for 7 min, with auto-extension of 20 s for the last 20 cycles, followed by 15 min at 68°C. Approximately 5 μL of the resulting PCR product was run on a 1% agarose gel to check for the presence of the desired product. Digestion was performed in a 12-μL total reaction volume containing 10 μL PCR product, 10 U XbaI enzyme (Promega), 1.2 μL XbaI restriction buffer (buffer D), and bovine serum albumin to a final concentration of 0.1 mg/mL. The digestion reaction was kept at 37°C overnight. The digestion product was run on a 1% agarose gel at 100 V until optimum band separation was achieved. The gel was stained with ethidium bromide and the bands were visualized by exposure to UV light.
Analysis of MspI/int22h-1 polymorphism
Long PCR was performed as reported by De Brasi et al. (1999) . Nested PCR was performed using the long PCR product as substrate (1 μL of a 1:500 dilution). PCR was performed in a 25-μL total reaction volume containing 1 μL diluted long PCR product, PCR buffer (Takara Taq buffer), 500 μM dNTP mixture, 1 U Taq DNA polymerase (Takara Bio Inc.), 0.4 μM each of the forward and reverse primers. The forward primer was 5'-GGTGCTCAG TAGCCTGTCGTTGTG-3' and the reverse primer was 5'-GCCACTACGCTCAGGTCCT GAGTC-3'. PCR cycling was performed in an MJR PTC200 thermocycler (MJ Research), as follows: 94°C for 5 min, followed by 30 cycles at 94°C for 30 s, 58°C for 60 s, 72°C for 60 s. Approximately 5 μL of the resulting PCR product was run on a 1% agarose gel to check for the presence of the desired product. Digestion was performed in a 12-μL total reaction volume containing 10 μL PCR product, 10 U MspI (New England Biolabs Inc., Beverly, MA, USA) and 1.2 μL NEB Buffer 2. The digestion reaction was kept at 37°C. This digestion product was run on a 3.5% agarose gel at 100 V until optimum band separation was achieved. The gel was stained with ethidium bromide and the bands were visualized by exposure to UV light.
Statistical analysis
To determine whether each single nucleotide polymorphism site was in Hardy-Weinberg equilibrium (HWE), the distributions of observed genotype frequencies and expected genotype frequencies were compared by the chi-square test using a website (http://ihg2. helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl). Haplotypes were estimated with Haploview (ver. 4.0). Linkage disequilibrium (LD) between the two polymorphic sites was estimated as relative disequilibrium (D') and correlation factor (r 2 ).
RESULTS
One hundred and one unrelated patients with severe hemophilia A, as well as their family members, were analyzed for the XbaI/int22h-1 and MspI/int22h-1 polymorphisms. Figure 1 shows schematically the positions of the polymorphic sites and amplification products for the analysis of XbaI/int22h-1 and MspI/int22h-1 polymorphisms. 
XbaI/int22h-1 polymorphism
The amplification product of XbaI long PCR was 6.2 kb (Figure 2A, lane 2) . The PCR product has an invariant 696-bp XbaI site located at the 5' end of the PCR product, which provided an internal digestion control (data not shown). While 5.5-and 0.7-kb fragments were obtained for XbaI A (-) DNA, the 5.5-kb fragment was further digested into 4.9-and 0.6-kb fragments for XbaI A (+) DNA (Figure 2A) . When the patients' mothers' DNA sequences were analyzed for the XbaI/int22h-1 polymorphism, the genotype (+,+) was found in 43 of 101 subjects, genotype (-,-) in 14 of 101, and genotype (+,-) in 44 of 101 (Table 1) . Thus, the heterozygosity rate was determined to be 43.6%. The (+) allele had a frequency of 0.644 and the (-) allele had a frequency of 0.356 (allele +/-= 0.644/0.356 ± 0.0345, 95%CI). 
MspI/int22h-1 polymorphism
For polymorphism analysis at the MspI polymorphic site, the long PCR product was used as a template for nested PCR. The long PCR product size was 6.6 kb and the nested PCR product size was 176 bp. As in the XbaI polymorphism analysis, the invariant 35-bp MspI site, located at the 3' end of the PCR product, provided an internal digestion control. While fragments of 141 and 35 bp were obtained for MspI A (-) DNA, the 141-bp fragment was further digested to fragments of 96 and 45 bp for MspI A (+) DNA (Figure 2) . When the patients' mothers' DNA sequences were analyzed for the MspI/int22h-1 polymorphism, the genotype (+,+) was found in 37 of 101 subjects, genotype (-,-) in 14 of 101, and genotype (+,-) in 50 of 101 (Table 1) . Thus, the heterozygosity rate was determined to be 49.5%. The (+) allele had a frequency of 0.61 and the (-) allele had a frequency of 0.39 (allele +/-= 0.61/0.39 ± 0.0335, 95%CI).
Linkage analysis between MspI/int22h-1 and XbaI/int22h-1
When the patients' mothers' DNA sequences were analyzed for MspI and XbaI haplotypes, the two polymorphic sites had a correlation factor of r 2 = 0.022, which indicates a lack of complete linkage disequilibrium. This finding is surprising, because the distance between these polymorphic sites is only 737 bp (Figure 1) . Therefore, when MspI and XbaI sites were analyzed together using allelic frequency and linkage data, a more informative rate was obtained. When the XbaI site was homozygous and therefore uninformative, additional informative rates of 16.8 and 5.9% were obtained for homozygous females with genotypes of XbaI (+,+) and XbaI (-,-), respectively. While analysis using only the XbaI site gave a 43.6% informative rate, analysis of the XbaI and MspI sites together gave an additional 22.7% informative rate (Table  2) . Thus, the informative rate increased to 66.3% with the use of both polymorphic sites. 
DISCUSSION
It is known that the polymorphic homologous regions int22h-2 and int22h-3 exist outside of intron 22 of the factor VIII gene on the X-chromosome (Naylor et al., 1995) . Thus, detection of the extragenic homologous regions could result in an incorrect diagnosis during polymorphic analysis of intron 22. Southern blot analyses of intron 22 polymorphisms could also result in an incorrect diagnosis due to the presence of two adjacent bands ( Van de Water et al., 1994) . Additionally, when conventional PCR was used, the 3' regions were amplified together and polymorphisms of the int22h-1 region could not be accurately distinguished (Kogan et al., 1987) . Because of these difficulties, the use of the XbaI/int22h-1 polymorphism has been restricted to the clinical diagnosis of hemophilia A. However, El-Maarri et al. (1999) developed a PCR-based analysis method that is specific for the XbaI/int22h-1 polymorphism. When El-Maarri et al. (1999) used this method to analyze the DNA of Turkish patients, they reported that XbaI/int22h-1 polymorphism analysis was effective for 60% of families who were uninformative with other intragenic markers. In subsequent studies, XbaI/int22h-1 polymorphism was reported to have a heterozygosity rate of 48-50%, which did not vary for different ethnic groups (Wion et al., 1986; Chan et al., 1989; Peake et al., 1993) .
In the present study, the expected heterozygosity rate for the XbaI/int22h-1 polymorphism in the Korean population was 43.6%, a value similar to the 48% heterozygosity rate in the Caucasian population (El-Maarri et al., 1999) . The value for the XbaI/int22h-1 polymorphism in the Korean population was much higher than the value (20%) for the BclI/intron 18 polymorphism in this same population (Choi et al., 2000) . Therefore, the XbaI/int22h-1 polymorphism is more useful for molecular genetic diagnosis of hemophilia A in the Korean population. In addition, the MspI polymorphism of int22h-1, which is 737 bp away from the XbaI polymorphism site, had a heterozygosity rate of 49.5%, and allelic frequencies were 0.61 and 0.39, respectively, for the (+) and (-) alleles (allele +/-= 0.61/0.39 ± 0.0335, 95%CI) in this study. These results are similar to those of Bowen et al. (2000) , where the heterozygosity rate was 0.46, and allelic frequencies were 0.65 and 0.35, respectively, for the (+) and (-) alleles in 85 male hemophilia A patients in South Wales. This information suggested that a slightly higher informative rate was obtained in the Korean population.
Even though the informative rate obtained with either the XbaI or MspI polymorphism of int22h-1 is slightly lower than those obtained with factor VIII introns 13 and 22 microsatellites (67 and 34%, respectively), the XbaI or MspI polymorphisms could compensate for weak points of the microsatellites, the allelic frequencies of which could fluctuate between generations (Jeffreys et al., 1988; Rubinsztein et al., 1995; Lee et al., 2009 ). Thus, we could obtain better diagnoses if introns 13 and 22 microsatellite data were first verified using the XbaI or MspI polymorphisms.
Our present study also showed that no complete LD existed between the MspI polymorphism and XbaI polymorphism in a Korean population and that simultaneous use of both polymorphisms provided an informative rate of 66.3%, indicating a high quality of molecular markers for hemophilia A. However, the experimental procedure for detection of the MspI polymorphism includes long PCR and nested PCR to exclude extragenic int22h-2 and int22h-3. The steps of this procedure are complicated and samples could be contaminated, resulting in an erroneous interpretation. In addition, DNA integrity has been the most important factor in similar experiments. However, if an experienced researcher performs the experiments and DNA integrity is guaranteed, a much higher informative rate can be obtained using the MspI polymorphism of int22h-1 for carrier detection and prenatal diagnosis of hemophilia A.
